MedPath

Carbohydrate Content in the Diet in Type 1 Diabetes

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 1
Interventions
Other: Moderate carbohydrate diet
Other: Higher carbohydrate diet
Registration Number
NCT03400618
Lead Sponsor
Vastra Gotaland Region
Brief Summary

The aim of this study is to analyse the effect of a diet with a moderate amount of carbohydrates and compare it with a traditional diabetic diet with a higher content of carbohydrates on mean glucose level, high and low glucose levels, and the risk of ketoacidosis in patients with type 1 diabetes. The glucose levels will be measured by blinded continuous glucose monitoring (CGM).

The trial has a cross-over design and 12 weeks in duration, where patients will be randomized to; 1) a diet with moderate carbohydrate content for 4 weeks and 2) a traditional diabetes diet for 4 weeks and with a wash-out period between for 4 weeks. The two diets will both be healthy and planned by a dietitian. There will be 50 subjects included in the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Type 1 diabetes
  • Adults 18 years or older
  • Written Informed Consent
  • HbA1c ≥ 58 mmol/mol (7,5 % DCCT standard)
Exclusion Criteria
  • Pregnancy or planned pregnancy for the study duration
  • Severe cognitive dysfunction or other disease, which is judged by the physician to be not suitable for inclusion
  • Problems with compliance to the intervention diets (excluding a lot of the foods that are common in the diets like wholegrain/beans/lentils/fruit/vegetables) because of personal preferences, other diseases, stomach problems etc.
  • Diabetes duration < 1 year
  • Planned change in diabetes treatment (eg. Start with insulin pump, CGM etc.) during the study period
  • Other investigator-determined criteria unsuitable for patient participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Moderate carbohydrate dietModerate carbohydrate dietA healthy diet containing 30 E % carbohydrates
Higher carbohydrate dietHigher carbohydrate dietA healthy diet containing 50 E % carbohydrates
Primary Outcome Measures
NameTimeMethod
The difference in mean glucose levelWeek 3-4, week 11-12

Measured by continuous glucose monitoring (CGM) between week 3-4 and week 11-12

Secondary Outcome Measures
NameTimeMethod
LDL cholesterolWeek 4, week 12

The difference in LDL cholesterol between week 4 and week 12

The difference in standard deviation of glucose levelsWeek 3-4, week 11-12

Measured by continuous glucose monitoring (CGM) between week 3-4 and week 11-12

Total insulin doseWeek 1-4, week 9-12

The difference in total insulin dose between week 1-4 and week 9-12

Diabetes Treatment Satisfaction Questionnaire (DTSQc) scoreWeek 12

The difference in DTSQc score at week 12

The difference in the proportion of time with euglycaemic levelsWeek 3-4, week 11-12

Measured by continuous glucose monitoring (CGM) between week 3-4 and week 11-12

HDL cholesterolWeek 4, week 12

The difference in HDL cholesterol between week 4 and week 12

Diabetes Treatment Satisfaction Questionnaire (DTSQs) scoreWeek 4, week 12

The difference in DTSQs scores between week 4 and week 12

The difference in the proportion of time with high glucose levelsWeek 3-4, week 11-12

Measured by continuous glucose monitoring (CGM) between week 3-4 and week 11-12

WeightWeek 4, week 12

The difference in weight between week 4 and week 12

Total cholesterolWeek 4, week 12

The difference in total cholesterol between week 4 and week 12

TriglyceridesWeek 4, week 12

The difference in triglycerides between week 4 and week 12

Hypoglycemia confidence scoreWeek 4, week 12

The difference in hypoglycaemia confidence scores between week 4 and week 12

Trial Locations

Locations (1)

NU Hospital Organization

🇸🇪

Uddevalla, Sweden

© Copyright 2025. All Rights Reserved by MedPath